Correlation Between Virpax Pharmaceuticals and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Pulmatrix, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Pulmatrix.
Diversification Opportunities for Virpax Pharmaceuticals and Pulmatrix
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Virpax and Pulmatrix is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Pulmatrix go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Pulmatrix
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Pulmatrix. In addition to that, Virpax Pharmaceuticals is 1.81 times more volatile than Pulmatrix. It trades about -0.03 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.05 per unit of volatility. If you would invest 379.00 in Pulmatrix on November 2, 2024 and sell it today you would earn a total of 388.00 from holding Pulmatrix or generate 102.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Pulmatrix
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Pulmatrix |
Virpax Pharmaceuticals and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Pulmatrix
The main advantage of trading using opposite Virpax Pharmaceuticals and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |